Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: December 2022

MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Looks for Strong Numbers in Upcoming Quarter

Posted on December 27, 2022 by MissionIR

FingerMotion (NASDAQ: FNGR), a mobile data and services company, is anticipating more than $10 million in quarter revenues for the period ended Nov. 30, 2022. The company announced that, based on expected revenue growth in its core businesses, the company … Continue reading →

Posted in FingerMotion Inc. FNGR | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Featured in Syndicated Broadcast, Secures New Contracts Spanning Multiple States

Posted on December 27, 2022 by MissionIR

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), was featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks – Vision Energy Corp. (VENG) Increases Core Team to Realize Project Development Objectives

Posted on December 27, 2022 by MissionIR

Vision Energy (OTCQB: VENG) today provided an update on the expansion of its project management and development team. According to the announcement, Vision Energy, through its wholly owned Dutch subsidiary Evolution Terminals BV (“ETBV”), continues work to realize its project … Continue reading →

Posted in Vision Energy Corp. VENG | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Uses Patented DehydraTECH(TM) Technology to Increase Bioavailability in Pharmaceuticals

Posted on December 27, 2022 by MissionIR

One of the main concerns associated with marketed drugs is low bioavailability. Bioavailability is the amount of a drug or substance that becomes completely available to the intended biological destination and is a measure of the rate and fraction of … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

Correlate Infrastructure Partners Inc. (CIPI) – Making Energy Transition Efficient, Transparent, and Cost-Effective

Posted on December 27, 2022 by MissionIR

According to the National Renewable Energy Laboratory, buildings are the largest consumers of energy and one of the largest sources of greenhouse gas (“GHG”) emissions in the United States. They account for 70% of electricity use and about 40% of … Continue reading →

Posted in Correlate Infrastructure Partners Inc. CIPI | Leave a comment

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces I-GO European Arrival

Posted on December 22, 2022 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has announced that its I-GO(TM) Commercial Urban Delivery EV has arrived in Europe; specifically, sample vehicles are on their way to Ireland-based Newgate Motor Group, with an expected delivery for … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – Cerberus Cyber Sentinel Corporation (NASDAQ: CISO) Announces Corporate Rebrand to Reflect Global Organization

Posted on December 22, 2022 by MissionIR

Cerberus Sentinel (NASDAQ: CISO), a Scottsdale, Arizona-based industry leader as a managed cybersecurity and compliance provider, today announced plans for a corporate rebrand and launch. Central to the rebranding is a change of the company name to CISO Global, Inc. … Continue reading →

Posted in Cerberus Cyber Sentinel Corp. CISO | Leave a comment

MissionIRNewsBreaks – Aegis Capital Corp. Acted as Sole Bookrunner on BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) $8M Underwritten Public Offering

Posted on December 22, 2022 by MissionIR

BiondVax (NASDAQ: BVXV) is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. Aegis Capital Corp., which is dedicated to providing corporate finance, strategic advisory and related services … Continue reading →

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Provides Updates of Recent Key Events and Plans for Calendar 2023; Announces Public Offering to Raise Funding for Operations

Posted on December 22, 2022 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP) CEO John Climaco recently participated in the Virtual Investor “Ask the CEO” Event held December 6. As part of the virtual event, Climaco discussed his and the company’s background, provided an update on recent key events … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

Luis Merchan, Helping Flora Growth Corp. (NASDAQ: FLGC) Become Global Leader in the CBD Space

Posted on December 22, 2022 by MissionIR

In July 2020, Flora Growth (NASDAQ: FLGC), a cannabis cultivator, brand manufacturer, and global distributor, appointed Luis Merchan as the President of Consumer Goods. Mr. Merchan would lead the company’s CBD portfolio, eventually launching four unique brands in the United … Continue reading →

Posted in Flora Growth Corp. FLGC | Leave a comment